Corneal Collagen Cross-linking for Keratoconus
Corneal collagen cross-linking (CXL) is currently the only treatment that may slow down the progression of keratoconus. It is a minimally invasive procedure to strengthen corneal tissue and stabilize the cornea’s shape.
If you have been diagnosed with keratoconus, or if you are concerned that your condition might be deteriorating, contact Dr. Walter Yim at Pacific Eye Care Doctors of Optometry to evaluate whether CXL is the best option for you.
What Is Corneal Collagen Cross-Linking?
Corneal collagen cross-linking is a surgical procedure performed by a corneal eye doctor or ophthalmologist to stabilize the shape and firmness of the cornea. By applying riboflavin (vitamin B2) eye drops and ultraviolet light, the surgical treatment promotes the building of new collagen fiber links within the cornea. In many cases, it helps prevent the need for a corneal transplant.
Collagen plays a vital role in creating and maintaining the smooth round shape of the eye’s surface. The tightness of the woven collagen fibers determines the strength of the corneal tissue. A weak cornea is prone to deformation, causing keratoconus to progress.
CXL is also effective in treating corneal ulcers in cases where topical antibiotics did not produce results. Several other corneal infections have also successfully been treated with CXL.


